Cargando…

Clinical Value and Prognosis of C Reactive Protein to Lymphocyte Ratio in Severe Aneurysmal Subarachnoid Hemorrhage

OBJECTIVE: To investigate the relationship between CLR and disease severity and clinical prognosis of aSAH. METHODS: The authors retrospectively analyzed the clinical data of 221 patients with aSAH, who were admitted to the intensive care unit from January 2017 to December 2020. The indicators of in...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Qingqing, Zhang, Gaoqi, Wang, Lintao, Zhang, Wanwan, Hou, Fandi, Zheng, Zhanqiang, Guo, Yong, Chen, Zhongcan, Hernesniemi, Juha, Andrade-Barazarte, Hugo, Feng, Guang, Gu, Jianjun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9234282/
https://www.ncbi.nlm.nih.gov/pubmed/35769371
http://dx.doi.org/10.3389/fneur.2022.868764
_version_ 1784736034611789824
author Zhang, Qingqing
Zhang, Gaoqi
Wang, Lintao
Zhang, Wanwan
Hou, Fandi
Zheng, Zhanqiang
Guo, Yong
Chen, Zhongcan
Hernesniemi, Juha
Andrade-Barazarte, Hugo
Feng, Guang
Gu, Jianjun
author_facet Zhang, Qingqing
Zhang, Gaoqi
Wang, Lintao
Zhang, Wanwan
Hou, Fandi
Zheng, Zhanqiang
Guo, Yong
Chen, Zhongcan
Hernesniemi, Juha
Andrade-Barazarte, Hugo
Feng, Guang
Gu, Jianjun
author_sort Zhang, Qingqing
collection PubMed
description OBJECTIVE: To investigate the relationship between CLR and disease severity and clinical prognosis of aSAH. METHODS: The authors retrospectively analyzed the clinical data of 221 patients with aSAH, who were admitted to the intensive care unit from January 2017 to December 2020. The indicators of inflammatory factors in the first blood routine examination within 48 h of bleeding were obtained. The prognosis was evaluated by mRS score at discharge, mRS>2 was a poor outcome. Through the receiver operating characteristic (ROC) curve, the area under the curve was calculated and the predicted values of inflammatory factors (CLR, CRP, WBC, and neutrophils) were compared. Univariate and multivariable logistic regression analyses were used to evaluate the relationship between CLR and the clinical prognosis of patients. ROC curve analysis was performed to determine the optimal cut-off threshold, sensitivity, and specificity of CLR in predicting prognosis at admission. RESULTS: According to the mRS score at discharge, 139 (62.90%) patients were classified with poor outcomes (mRS>2). The inflammatory factor with the best predictive value was CLR, which had an optimal cut-off threshold of 10.81 and an area under the ROC curve of 0.840 (95%CI.788–0.892, P < 0.001). Multivariable Logistic regression analysis showed that the Modified Fisher grade, Hunt-Hess grade, and CLR at admission were independent risk factors for poor outcomes of patients with aSAH (P < 0.05). According to Hunt-Hess grade, patients were divided into a mild group (Hunt-Hess ≤ 3) and a severe group (Hunt-Hess > 3), and the CLR value was significantly higher in severe patients with aSAH than in mild patients. The optimal cut-off threshold of CLR in the severe group was 6.87, and the area under the ROC curve was 0.838 (95% CI.752–0.925, P < 0.001). CONCLUSIONS: The CLR value at the admission of patients with aSAH was significantly associated with Hunt-Hess grade, The higher Hunt-Hess grade, the higher the CL R-value, and the worse the prognosis. Early CLR value can be considered as a feasible biomarker to predict the clinical prognosis of patients with aSAH.
format Online
Article
Text
id pubmed-9234282
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-92342822022-06-28 Clinical Value and Prognosis of C Reactive Protein to Lymphocyte Ratio in Severe Aneurysmal Subarachnoid Hemorrhage Zhang, Qingqing Zhang, Gaoqi Wang, Lintao Zhang, Wanwan Hou, Fandi Zheng, Zhanqiang Guo, Yong Chen, Zhongcan Hernesniemi, Juha Andrade-Barazarte, Hugo Feng, Guang Gu, Jianjun Front Neurol Neurology OBJECTIVE: To investigate the relationship between CLR and disease severity and clinical prognosis of aSAH. METHODS: The authors retrospectively analyzed the clinical data of 221 patients with aSAH, who were admitted to the intensive care unit from January 2017 to December 2020. The indicators of inflammatory factors in the first blood routine examination within 48 h of bleeding were obtained. The prognosis was evaluated by mRS score at discharge, mRS>2 was a poor outcome. Through the receiver operating characteristic (ROC) curve, the area under the curve was calculated and the predicted values of inflammatory factors (CLR, CRP, WBC, and neutrophils) were compared. Univariate and multivariable logistic regression analyses were used to evaluate the relationship between CLR and the clinical prognosis of patients. ROC curve analysis was performed to determine the optimal cut-off threshold, sensitivity, and specificity of CLR in predicting prognosis at admission. RESULTS: According to the mRS score at discharge, 139 (62.90%) patients were classified with poor outcomes (mRS>2). The inflammatory factor with the best predictive value was CLR, which had an optimal cut-off threshold of 10.81 and an area under the ROC curve of 0.840 (95%CI.788–0.892, P < 0.001). Multivariable Logistic regression analysis showed that the Modified Fisher grade, Hunt-Hess grade, and CLR at admission were independent risk factors for poor outcomes of patients with aSAH (P < 0.05). According to Hunt-Hess grade, patients were divided into a mild group (Hunt-Hess ≤ 3) and a severe group (Hunt-Hess > 3), and the CLR value was significantly higher in severe patients with aSAH than in mild patients. The optimal cut-off threshold of CLR in the severe group was 6.87, and the area under the ROC curve was 0.838 (95% CI.752–0.925, P < 0.001). CONCLUSIONS: The CLR value at the admission of patients with aSAH was significantly associated with Hunt-Hess grade, The higher Hunt-Hess grade, the higher the CL R-value, and the worse the prognosis. Early CLR value can be considered as a feasible biomarker to predict the clinical prognosis of patients with aSAH. Frontiers Media S.A. 2022-06-13 /pmc/articles/PMC9234282/ /pubmed/35769371 http://dx.doi.org/10.3389/fneur.2022.868764 Text en Copyright © 2022 Zhang, Zhang, Wang, Zhang, Hou, Zheng, Guo, Chen, Hernesniemi, Andrade-Barazarte, Feng and Gu. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Neurology
Zhang, Qingqing
Zhang, Gaoqi
Wang, Lintao
Zhang, Wanwan
Hou, Fandi
Zheng, Zhanqiang
Guo, Yong
Chen, Zhongcan
Hernesniemi, Juha
Andrade-Barazarte, Hugo
Feng, Guang
Gu, Jianjun
Clinical Value and Prognosis of C Reactive Protein to Lymphocyte Ratio in Severe Aneurysmal Subarachnoid Hemorrhage
title Clinical Value and Prognosis of C Reactive Protein to Lymphocyte Ratio in Severe Aneurysmal Subarachnoid Hemorrhage
title_full Clinical Value and Prognosis of C Reactive Protein to Lymphocyte Ratio in Severe Aneurysmal Subarachnoid Hemorrhage
title_fullStr Clinical Value and Prognosis of C Reactive Protein to Lymphocyte Ratio in Severe Aneurysmal Subarachnoid Hemorrhage
title_full_unstemmed Clinical Value and Prognosis of C Reactive Protein to Lymphocyte Ratio in Severe Aneurysmal Subarachnoid Hemorrhage
title_short Clinical Value and Prognosis of C Reactive Protein to Lymphocyte Ratio in Severe Aneurysmal Subarachnoid Hemorrhage
title_sort clinical value and prognosis of c reactive protein to lymphocyte ratio in severe aneurysmal subarachnoid hemorrhage
topic Neurology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9234282/
https://www.ncbi.nlm.nih.gov/pubmed/35769371
http://dx.doi.org/10.3389/fneur.2022.868764
work_keys_str_mv AT zhangqingqing clinicalvalueandprognosisofcreactiveproteintolymphocyteratioinsevereaneurysmalsubarachnoidhemorrhage
AT zhanggaoqi clinicalvalueandprognosisofcreactiveproteintolymphocyteratioinsevereaneurysmalsubarachnoidhemorrhage
AT wanglintao clinicalvalueandprognosisofcreactiveproteintolymphocyteratioinsevereaneurysmalsubarachnoidhemorrhage
AT zhangwanwan clinicalvalueandprognosisofcreactiveproteintolymphocyteratioinsevereaneurysmalsubarachnoidhemorrhage
AT houfandi clinicalvalueandprognosisofcreactiveproteintolymphocyteratioinsevereaneurysmalsubarachnoidhemorrhage
AT zhengzhanqiang clinicalvalueandprognosisofcreactiveproteintolymphocyteratioinsevereaneurysmalsubarachnoidhemorrhage
AT guoyong clinicalvalueandprognosisofcreactiveproteintolymphocyteratioinsevereaneurysmalsubarachnoidhemorrhage
AT chenzhongcan clinicalvalueandprognosisofcreactiveproteintolymphocyteratioinsevereaneurysmalsubarachnoidhemorrhage
AT hernesniemijuha clinicalvalueandprognosisofcreactiveproteintolymphocyteratioinsevereaneurysmalsubarachnoidhemorrhage
AT andradebarazartehugo clinicalvalueandprognosisofcreactiveproteintolymphocyteratioinsevereaneurysmalsubarachnoidhemorrhage
AT fengguang clinicalvalueandprognosisofcreactiveproteintolymphocyteratioinsevereaneurysmalsubarachnoidhemorrhage
AT gujianjun clinicalvalueandprognosisofcreactiveproteintolymphocyteratioinsevereaneurysmalsubarachnoidhemorrhage